Prime Medicine, Inc.
PRME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $889,188 | $319,089 | $260,460 | $346,313 |
| - Cash | $71,396 | $53,804 | $91,877 | $182,476 |
| + Debt | $118,135 | $119,736 | $121,151 | $40,794 |
| Enterprise Value | $935,927 | $385,021 | $289,734 | $204,631 |
| Revenue | $1,225 | $1,115 | $1,454 | $2,183 |
| % Growth | 9.9% | -23.3% | -33.4% | – |
| Gross Profit | -$42,765 | -$749 | $1,454 | $2,183 |
| % Margin | -3,491% | -67.2% | 100% | 100% |
| EBITDA | -$48,701 | -$51,513 | -$50,692 | -$42,505 |
| % Margin | -3,975.6% | -4,620% | -3,486.4% | -1,947.1% |
| Net Income | -$50,582 | -$52,591 | -$51,890 | -$42,276 |
| % Margin | -4,129.1% | -4,716.7% | -3,568.8% | -1,936.6% |
| EPS Diluted | -0.32 | -0.407 | -0.397 | -0.357 |
| % Growth | 21.4% | -2.7% | -11.2% | – |
| Operating Cash Flow | -$35,039 | -$41,412 | -$48,857 | $16,245 |
| Capital Expenditures | -$247 | -$1,572 | -$2,422 | -$1,791 |
| Free Cash Flow | -$35,286 | -$42,984 | -$51,279 | $14,454 |